Baird Maintains Outperform on National Healthcare, Raises Price Target to $18

Benzinga Newsdesk www.benzinga.com Positive 91.1%

Neg 0% Neu 0% Pos 91.1%

Baird analyst Wesley Golladay maintains National Healthcare (NASDAQ:NHP) with a Outperform and raises the price target from $17 to $18.